Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 6, 2015, Pages 1413-1417

  Stein Zamir, C ^a,b   Schroeder, H ^a,b   Shoob, H ^a   Abramson, N ^a   Zentner, G ^a  

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adolescents; Children; Clinical presentation; Hospitalization; Mumps; Outbreak; Vaccination status

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUMPS VACCINE;

ADOLESCENT; ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; FEMALE; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUMPS; NEWBORN; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; VACCINATION; YOUNG ADULT; ADULT; AGED; COMPLICATION; EPIDEMIC; IMMUNOLOGY; ISRAEL; MENINGOENCEPHALITIS; ORCHITIS; PATHOLOGY; UTILIZATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; ISRAEL; MALE; MENINGOENCEPHALITIS; MIDDLE AGED; MUMPS; MUMPS VACCINE; ORCHITIS; VACCINATION; YOUNG ADULT;

EID: 84944452515     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1021522     Document Type: Article

References (25)

1. Rubin SA, Plotkin SA. Mumps vaccine. In: Plotkin SA, Orenstein W, Offit PA, editors. Vaccines, 6th Edition. Elsevier, 2013. pp 419-46.
2. Hviid A1, Rubin S, Mühlemann K. Mumps. Lancet. 2008 Mar 15; 371(9616):932-44; http://dx. doi. org/ 10. 1016/S0140-6736(08)60419-5
3. Centers for Disease Control and Prevention (CDC). Chapter 14: Mumps. In: Atkinson W, Wolfe C, Hamborsky J, editors. Epidemiology and Prevention of Vaccine- Preventable Diseases. 12th ed. Washington DC: Public Health Foundation; 2012. pp. 205-21.
4. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, et al. Recent Resurgence of Mumps in the United States. N Engl J Med 2008;358 (15):1580-9; PMID:18403766; http://dx. doi. org/ 10. 1056/NEJMoa0706589
5. Slater PE, Anis E, Leventhal A. The control of mumps in Israel. Eur J Epidemiol 1999 Sep; 15(8):765-7.; http://dx. doi. org/10. 1023/A:1007663429371
6. Ministry of Health, State of Israel, Israel Center for Disease Control (ICDC). Notifiable Infectious diseases in Israel: 60 y of surveillance, 1951-2010. 2012. Available at: www. health. gov. il/publicationsfiles/Dis ease1951_2010. pdf. Accessed 9/2014
7. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012 Nov;367(18):1704-13; http://dx. doi. org/10. 1056/NEJMoa1202865
8. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. EuroSurveill 2009 Dec 17; 14(50).
9. Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: are 2 doses enough? Epidemiol Infect 2012 Mar; 140(3):439-46; http://dx. doi. org/10. 1017/ S095026881100063X
10. Population of Israel and Jerusalem district by Population Group (table 2. 10). In: Statistical abstract of Israel no. 63. Jerusalem, Israel 2012. Available at: http:// www. cbs. gov. il/
11. Levine H, Rishpon S, Huerta-Hartal M, Davidovitch N. Preventing mumps outbreaks in confined settings: comprehensive ring vaccination as a containment strategy. Hum Vaccin 2011 Dec;7(12):1389-93; http://dx. doi. org/10. 4161/hv. 7. 12. 18111
12. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63 (6):1055-68.
13. Kutty PK, Lawler J, Rausch-Phung E, Ortega-Sanchez IR, Goodell S, Schulte C, Pollock L, Valure B, Hudson J, Gallagher K, et al. Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010. Hum Vaccin Immunother 2014 May;10(5):1373-81; PMID:24633360; http://dx. doi. org/10. 4161/hv. 28389
14. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis 2011; 17(4):661-7; PMID:21470456; http://dx. doi. org/10. 3201/eid1704. 101461
15. World Health Organization. Regional office for Europe. The centralized information system for infectious diseases (CISID). Mumps - Number of cases. Available in: http://data. euro. who. int/cisid/? TabID=361790
16. World Health Organization. Distribution of reported mumps genotypes, 2005-2011. Data as of 20 April 2012. Available in:http://www. who. int/immunization/ monitoring_surveillance/burden/vpd/surveillance_type /passive/mumpsgenotype
17. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 2013 Mar; 141 (3):651-66.; http://dx. doi. org/10. 1017/ S0950268812001136
18. Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2012 Feb 15; 2: CD004407
19. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13(1):12-7; PMID:17370510; http://dx. doi. org/10. 3201/eid1301. 060649
20. Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, Hahné S. Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis 2014 Apr; 20(4):643-8; http:// dx. doi. org/10. 3201/eid2004. 131681
21. Takla A, Böhmer MM, Klinc C, Kurz N, Schaffer A, Stich H, Stöcker P, Wichmann O, Koch J. Outbreakrelated mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Hum Vaccin Immunother 2014 Jan;10(1):140-5; http://dx. doi. org/10. 4161/hv. 26642
22. Stein-Zamir C, Zentner G, Abramson N, Shoob H, Aboudy Y, Shulman L, Mendelson E. Measles outbreaks affecting children in Jewish ultra-Orthodox communities in Jerusalem. Epidemiol Infect 2008 Feb; 136(2):207-14.
23. Stein-Zamir C, Abramson N, Shoob H, Zentner G. An outbreak of measles in an ultra-Orthodox Jewish community in Jerusalem, Israel, 2007-an in-depth report. Euro Surveill 2008 Feb 21; 13(8) pii: 8045.
24. Stein-Zamir C, Shoob H, Abramson N, Zentner G. Who are the children at risk? Lessons learned from measles outbreaks. Epidemiol Infect. 2012 Sep; 140 (9):1578-88; http://dx. doi. org/10. 1017/ S095026881100238X
25. Parker Fiebelkorn A, Rosen JB, Brown C, Zimmerman CM, Renshowitz H, D'Andrea C, Gallagher KM, Harpaz R, Zucker JR. Environmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010. Hum Vaccin Immunother. 2013 Jan 1; 9(1):189-94; http://dx. doi. org/10. 4161/hv. 22415